Intracerebral Hemorrhage
234
54
65
77
Key Insights
Highlights
Success Rate
81% trial completion
Published Results
25 trials with published results (11%)
Research Maturity
77 completed trials (33% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
7.7%
18 terminated out of 234 trials
81.1%
-5.5% vs benchmark
11%
26 trials in Phase 3/4
32%
25 of 77 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 77 completed trials
Clinical Trials (234)
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
Targeted Temperature Management Via Bladder Monitoring in ICH
Microplastics in Brain Hematomas and Neurological Outcomes After Intracerebral Hemorrhage
GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized Trial
Optical Coherence Tomography Angiography in Neurological Disease
Transitions of Care for Stroke Patients
Oral Anticoagulation After Stroke With Prior ICH in Subjects With AF
International Care Bundle Evaluation in Cerebral Hemorrhage Research
Prospective Italian Validation of SMS in Patients With Suspected Acute Stroke
Ex Vivo Reproduction of Minimally Invasive Surgery With Hematoma Lysis Using Modified Tissue Plasminogen Activator for Intracerebral Hemorrhage
Role of Neuroinflammation and Blood-Brain Barrier Breakdown in Intracerebral Hemorrhage.
Florida Cerebrovascular Disease Biorepository and Genomics Center
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Evaluating a Prototype CT Scan for ICH Evacuation
Vitamin D for Acute Intracerebral Hemorrhage
Tenecteplase (TNK) in the Treatment of Intracerebral Hemorrhage (ICH)
AI-Guided Hematoma Aspiration vs. Conservative Treatment for Spontaneous ICH
Efficacy and Safety of Minocycline in Acute Spontaneous Intracerebral Hemorrhage
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Statins In Intracerbral Hemorrhage